If you need more lookups,
subscriptions start at $34 USD/month.
Steve Dingman Location
Cambridge, MA, US
Steve Dingman Work
2024 -now Vice President, Pharmacovigilance, Head of Safety @
2022 -2024 Vice President, Pharmacovigilance at ImmunoGen @
2019 -2022 Vice President, Drug Safety and Pharmacovigilance @
2017 -2019 Senior Medical Director @
2011 -2017 Senior Medical Director, Global Pharmacovigilance @
2010 -2011 Global Drug Safety Physician @
2008 -2009 Senior Director, Medical Affairs and Pharmacovigilance @ SRA Global Clinical Development, LLC
2006 -2008 Medical Director @ SRA Global Clinical Development, LLC
Steve Dingman Education
University of Iowa
North Carolina State University
The University of North Carolina at Chapel Hill
Steve Dingman Skills
CRO
Clinical Development
Clinical Trials
Drug Safety
Medical Affairs
Pharmacovigilance
Oncology
GCP
Pharmaceutical Industry
Regulatory Submissions
Clinical Research
Drug Development
Medicine
Biotechnology
Regulatory Affairs
Leadership
Customer Service
Steve Dingman Summary
Steve Dingman, based in Cambridge, MA, US, is currently a Vice President, Pharmacovigilance, Head of Safety at Merus N.V.. Steve Dingman brings experience from previous roles at ImmunoGen, Inc., Alkermes, Clovis Oncology and AbbVie. Steve Dingman holds a University of Iowa. With a robust skill set that includes CRO, Clinical Development, Clinical Trials, Drug Safety, Medical Affairs and more. Steve Dingman has 2 emails on RocketReach.
Looking for a different Steve Dingman?
Find contact details for 700 million professionals.